Shire's Ornskov on $1 Billion Potential for Dry-Eye Drug(Audio)
Jul 12, 2016
08:00
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Shire CEO Flemming Ornskov on the outlook for the company after getting FDA approval for Xiidra drops to treat dry-eye disease.
